Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia-Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Cardiovascular Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing prevalence of cardiovascular diseases
3.3.1.2. Technological advancements
3.3.1.3. Aging population
3.3.2. Market restraint analysis
3.3.2.1. Regulatory challenges
3.3.2.2. High cost of development
3.4. Cardiovascular Devices Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Pipeline Analysis
Chapter 4. Cardiovascular Devices: Product Estimates & Trend Analysis
4.1. Cardiovascular Devices Market: Product Key Takeaways
4.2. Cardiovascular Devices Market: Product Movement & Market Share Analysis, 2024 & 2033
4.3. Diagnostic and Monitoring Devices
4.3.1. Diagnostic and monitoring devices estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.1. ECG
4.3.1.1.1. ECG market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.2. Implantable Cardiac Monitors
4.3.1.2.1. Implantable cardiac monitors market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.3. Holter Monitors
4.3.1.3.1. Holter monitors market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.4. Mobile Cardiac Telemetry
4.3.1.4.1. Mobile cardiac telemetry market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.5. MRI
4.3.1.5.1. MRI estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6. Cardiovascular Ultrasound
4.3.1.6.1. Cardiovascular ultrasound market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6.2. 2D
4.3.1.6.2.1. 2D market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6.3. 3D/4D
4.3.1.6.3.1. 3D/4D market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6.4. Doppler
4.3.1.6.4.1. Doppler market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.7. Cardiac Diagnostic Catheters
4.3.1.7.1. Cardiac diagnostic catheters market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.8. PET Scanner
4.3.1.8.1. PET scanner market estimates and forecasts, 2021 to 2033 (USD Million)
4.4. Surgical Devices
4.4.1. Surgical devices market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.1. Cardiac Resynchronization Therapy (CRT)
4.4.1.1.1. Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.1.2. CRT-Defibrillator
4.4.1.1.2.1. CRT-defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.1.3. CRT-Pacemaker
4.4.1.1.3.1. CRT-pacemaker market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.2. Implantable Cardioverter Defibrillators (ICDs)
4.4.1.2.1. Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.2.2. Single Chamber ICDs
4.4.1.2.2.1. Single chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.2.3. Dual Chamber ICDs
4.4.1.2.3.1. Dual chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.3. Pacemakers
4.4.1.3.1. Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.3.2. Conventional Pacemakers
4.4.1.3.2.1. Conventional pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.3.3. Leadless Pacemakers
4.4.1.3.3.1. Leadless pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.4. Coronary Stents
4.4.1.4.1. Coronary stents market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.5. Catheters
4.4.1.5.1. Catheters market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.6. Guidewires
4.4.1.6.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.7. Cannula
4.4.1.7.1. Cannula market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.8. Valves
4.4.1.8.1. Valves market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.9. Occlusion devices
4.4.1.9.1. Occlusion devices market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country and Product
5.1. Regional Dashboard
5.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
5.3. North America
5.3.1. U.S.
5.3.1.1. Key country dynamics
5.3.1.2. Regulatory framework/ reimbursement structure
5.3.1.3. Competitive scenario
5.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
5.3.2. Canada
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Germany
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. France
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4. Italy
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6. Norway
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Asia-Pacific
5.5.1. Japan
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. India
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. Australia
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2. Argentina
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3. Mexico
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
5.7.3. UAE
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
5.7.4. Kuwait
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.2.2. Key customers
6.2.3. Key company market share analysis, 2024
6.3. Market Participant Categorization
6.3.1. Abbott
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. GE HealthCare
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Edwards Lifesciences Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. W. L. Gore & Associates, Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Siemens Healthcare GmbH
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. BIOTRONIK SE & Co. KG
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Canon Medical Systems Asia Pte. Ltd.
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. B. Braun SE
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. LivaNova PLC
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Cardinal Health
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Medtronic
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Boston Scientific Corporation
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 3 North America cardiovascular devices market, by region, 2021-2033 (USD Million)
Table 4 U.S. cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 5 Canada cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 6 Mexico cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 7 Europe cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 8 Europe cardiovascular devices market, by region, 2021-2033 (USD Million)
Table 9 Germany cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 10 UK cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 11 France cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 12 Italy cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 13 Spain cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 14 Sweden cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 15 Norway cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 16 Denmark cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 17 Asia-Pacific cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 18 Asia-Pacific cardiovascular devices market, by region, 2021-2033 (USD Million)
Table 19 China cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 20 Japan cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 21 India cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 22 Australia cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 23 Thailand cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 24 South Korea cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 25 Latin America cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 26 Latin America cardiovascular devices market, by region, 2021-2033 (USD Million)
Table 27 Brazil cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 28 Argentina cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 29 Middle East and Africa cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 30 Middle East and Africa cardiovascular devices market, by region, 2021-2033 (USD Million)
Table 31 South Africa cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 32 Saudi Arabia cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 33 UAE cardiovascular devices market, by product, 2021-2033 (USD Million)
Table 34 Kuwait cardiovascular devices market, by product, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Cardiovascular devices market: Market outlook
Figure 9 Cardiovascular devices market: Competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Cardiovascular devices market driver impact
Figure 15 Cardiovascular devices market restraint impact
Figure 16 Cardiovascular devices market strategic initiatives analysis
Figure 17 Cardiovascular devices market: Product movement analysis
Figure 18 Cardiovascular devices market: Product outlook and key takeaways
Figure 19 Diagnostic and monitoring devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 20 ECG market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Implantable cardiac monitors market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Holter monitors market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Mobile cardiac telemetry market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 MRI market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Cardiovascular ultrasound market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 2D market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 3D/4D market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Doppler market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Cardiac diagnostic catheters market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Pet scan market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 MRI market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Cardiac CT market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Doppler fetal monitors market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 PET scanner market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Surgical devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 CRT-defibrillator market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 CRT-pacemaker market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Single Chamber ICDs market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Dual Chamber ICDs market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Pacemakers market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Conventional pacemakers market estimates and forecasts, 2021-2033 (USD Million
Figure 44 Leadless pacemaker market estimates and forecasts, 2021-2033 (USD Million
Figure 45 Coronary stents market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Guidewires market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Cannula market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Valves market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Occlusion devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Global cardiovascular devices market: Regional movement analysis
Figure 51 Global cardiovascular devices market: Regional outlook and key takeaways
Figure 52 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 Middle East and Africa. market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Kuwait market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Market share of key market players cardiovascular devices market
